Clinical Trial Update: Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension [Phase 2]

View source ↗

Summary

Phase 2 results from a safety and benefit study of droxidopa for intradialytic hypotension have been posted, indicating potential safety and efficacy signals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intradialytic Hypotension

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Intradialytic Hypotension | Phase 2 | Status: COMPLETED | Results posted: 2014-06-27